In the lead up to World Tuberculosis (TB) Day this Saturday, March 24, the TB Alliance announced the launch of a new trial to test a combination drug regimen in patients with drug-sensitive TB as well as patients with multidrug-resistant (MDR) TB – the first time this has ever been done. Called “NC-002,” the eight-week […]
Plan to develop new vaccines could help stop TB in our children’s lifetimes
The following is a guest blog post by Dr. Lucica Ditiu, executive secretary of the Stop TB Partnership, commenting on the newly released document Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade, reflecting the consensus of members of the TB vaccine research and development community to develop new vaccines that could help stop TB in our children’s lifetimes.
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
Wuhan City in the Hubei Province of the People’s Republic of China is on the Yangtze River and is the most populous city in central China. […]